Day One Biopharmaceuticals Inc (NASDAQ:DAWN)’s traded shares stood at 1.88 million during the last session, with the company’s beta value hitting -1.37. At the close
In last trading session, Day One Biopharmaceuticals Inc (NASDAQ:DAWN) saw 0.61 million shares changing hands with its beta currently measuring -1.44. Company’s recent per share
During the last session, Day One Biopharmaceuticals Inc (NASDAQ:DAWN)’s traded shares were 1.38 million, with the beta value of the company hitting -1.46. At the
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) has a beta value of -1.49 and has seen 1.1 million shares traded in the last trading session. The company,
During the last session, Day One Biopharmaceuticals Inc (NASDAQ:DAWN)’s traded shares were 1.58 million, with the beta value of the company hitting -1.49. At the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
